5F-SDB-006
5F-SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors, with an EC50 of 50 nM for human CB1 receptors, and 123 nM for human CB2 receptors. It was discovered during research into the related compound APICA which had been sold illicitly as "2NE1". 5F-SDB-006 is the terminally fluorinated analog of SDB-006, just as STS-135 is the terminally fluorinated analog of APICA. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-SDB-006 may release benzylamine.
primaryTopic
5F-SDB-006
5F-SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors, with an EC50 of 50 nM for human CB1 receptors, and 123 nM for human CB2 receptors. It was discovered during research into the related compound APICA which had been sold illicitly as "2NE1". 5F-SDB-006 is the terminally fluorinated analog of SDB-006, just as STS-135 is the terminally fluorinated analog of APICA. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-SDB-006 may release benzylamine.
has abstract
5F-SDB-006 is a drug that acts ...... B-006 may release benzylamine.
@en
CAS number
1776086-02-2
FDA UNII code
4UP4SXX8BW
PubChem
Wikipage page ID
47,064,939
page length (characters) of wiki page
Wikipage revision ID
984,223,072
Link from a Wikipage to another Wikipage
CAS number
ChemSpiderID
30,646,773
IUPAC name
N-benzyl-1--1H-indole-3-carboxamide
@en
legal CA
Schedule II
@en
legal DE
Anlage II
@en
legal UK
Class B
@en
PubChem
91,936,847
SMILES
FCCCCCN1C=CC3=C1C=CC=C3
@en
StdInChIKey
VFLXAWVAWXHMFB-UHFFFAOYSA-N
@en
wikiPageUsesTemplate
hypernym
comment
5F-SDB-006 is a drug that acts ...... B-006 may release benzylamine.
@en
label
5F-SDB-006
@en